410 related articles for article (PubMed ID: 25688877)
21. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
23. N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.
Lowery JW; Amich JM; Andonian A; Rosen V
Cell Mol Life Sci; 2014 Aug; 71(16):3165-72. PubMed ID: 24337809
[TBL] [Abstract][Full Text] [Related]
24. Trapping of BMP receptors in distinct membrane domains inhibits their function in pulmonary arterial hypertension.
Jiang Y; Nohe A; Bragdon B; Tian C; Rudarakanchana N; Morrell NW; Petersen NO
Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L218-27. PubMed ID: 21622843
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension.
Rudarakanchana N; Flanagan JA; Chen H; Upton PD; Machado R; Patel D; Trembath RC; Morrell NW
Hum Mol Genet; 2002 Jun; 11(13):1517-25. PubMed ID: 12045205
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
Wong WK; Knowles JA; Morse JH
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
[TBL] [Abstract][Full Text] [Related]
27. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.
Gu M; Shao NY; Sa S; Li D; Termglinchan V; Ameen M; Karakikes I; Sosa G; Grubert F; Lee J; Cao A; Taylor S; Ma Y; Zhao Z; Chappell J; Hamid R; Austin ED; Gold JD; Wu JC; Snyder MP; Rabinovitch M
Cell Stem Cell; 2017 Apr; 20(4):490-504.e5. PubMed ID: 28017794
[TBL] [Abstract][Full Text] [Related]
28. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
29. 4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension.
Dunmore BJ; Yang X; Crosby A; Moore S; Long L; Huang C; Southwood M; Austin ED; Rana A; Upton PD; Morrell NW
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):160-171. PubMed ID: 32255665
[TBL] [Abstract][Full Text] [Related]
30. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
31. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
32. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
33. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2.
Kim MJ; Park SY; Chang HR; Jung EY; Munkhjargal A; Lim JS; Lee MS; Kim Y
BMB Rep; 2017 Jun; 50(6):308-317. PubMed ID: 28391780
[TBL] [Abstract][Full Text] [Related]
35. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
Harper RL; Reynolds AM; Bonder CS; Reynolds PN
Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
Morrell NW
Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin enhances bone morphogenetic protein receptor type II expression.
Hu H; Sung A; Zhao G; Shi L; Qiu D; Nishimura T; Kao PN
Biochem Biophys Res Commun; 2006 Jan; 339(1):59-64. PubMed ID: 16297860
[TBL] [Abstract][Full Text] [Related]
38. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane.
Nishibori Y; Liu L; Hosoyamada M; Endou H; Kudo A; Takenaka H; Higashihara E; Bessho F; Takahashi S; Kershaw D; Ruotsalainen V; Tryggvason K; Khoshnoodi J; Yan K
Kidney Int; 2004 Nov; 66(5):1755-65. PubMed ID: 15496146
[TBL] [Abstract][Full Text] [Related]
39. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
40. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
Wang Y; Zhang XH; Wang HL
Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
